Results 121 to 130 of about 15,884 (195)

Monitoring Adherence and Renal Safety of Nucleos(t)ide Analogs for Patients With Chronic Hepatitis B. [PDF]

Clin Transl Gastroenterol
Hsu CC, Chen ZE, Chao FH, Chou CY, Chang YL, Chou YC, Hou MC, Wu JC, Su CW.   +8 more
europepmc   +1 more source

Tenofovir vs. entecavir in chronic hepatitis B: A retrospective cohort study of hepatocellular carcinoma risk in a tertiary hospital in southern Brazil. [PDF]

Braz J Infect Dis
Stamm AN, Tovo CV, Noal A, Silva CU, Pizzi J, Fonseca PM, Kliemann DA.   +6 more
europepmc   +1 more source

The effect of treatment cessation on HBsAg negativity in HBeAg-negative chronic hepatitis B patients treated with nucleos(t)id analogues for more than three years. [PDF]

BMC Infect Dis
Senol Yilmaz A, Turker N.
europepmc   +1 more source

On-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational study [PDF]

, 2013

core   +1 more source

Nonadherence to Antiviral Therapy Leading to Severe Hepatic Decompensation in a Patient With Chronic Hepatitis B. [PDF]

ACG Case Rep J
Ahmad S, Paracha S, Ali R, Akbar SMA, Asif MA, Saeed MO, Bai R, Afzal HMT, Shah SB, Lau DTY.   +9 more
europepmc   +1 more source

PG110 ONCE DAILY MESALAZINE FOR MAINTAINING REMISSION IS COST-SAVING COMPARED TO TWICE DAILY MESALAZINE: AN ECONOMIC EVALUATION BASED ON THE PODIUM RANDOMISED CONTROLLED TRIAL [PDF]

, 2008
Connolly, M, Nielsen, SK, Currie, CJ, Poole, CD   +3 more
core   +1 more source

Exploratory analysis of lamivudine legacy and clonal selection of HBs truncation mutants in HBV-related hepatocellular carcinoma. [PDF]

Infect Agent Cancer
Chu YD, Ho PH, Hsu CW, Chiou CY, Lai MW, Yeh CT.   +5 more
europepmc   +1 more source

Ishak stage 6 fibrosis is more likely to regress than stage 5 in CHB patients undergoing entecavir therapy. [PDF]

Front Med (Lausanne)
Li M, Hao X, Li Y, Zhang C, Chen Y, Yu Z, Li Q, Tan L, Xiang D, Shang Q, Lei C, Chen L, Hu X, Wang J, Liu H, Lu W, Chen Y, Dong Z, Bai W, Yoshida EM, Mendez-Sanchez N, Hu KQ, Qi X, Yang Y, Bi J.   +24 more
europepmc   +1 more source

Long-term HBsAg clearance, relapse, and safety following tenofovir or entecavir discontinuation in non-cirrhotic, HBeAg-negative chronic hepatitis. [PDF]

Sci Rep
Sattayalertyanyong O, Bandidniyamanon W, Limsrivilai J, Chotiyaputta W, Nimanong S, Tanwandee T.   +5 more
europepmc   +1 more source

Real-World Effectiveness of Antiviral Prophylaxis for Preventing Hepatitis B Virus (HBV) Reactivation in Patients Undergoing Immunosuppressive Therapy. [PDF]

Viruses
Yılmaz Nakir İ, Çağlar B, Zerdali E, Karaduman RG, Pehlivanoğlu F.   +4 more
europepmc   +1 more source